P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development
- 1 March 2000
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 49 (3) , 187-200
- https://doi.org/10.1002/(sici)1098-2299(200003)49:3<187::aid-ddr9>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Calcium Signalling via Multiple P2 Purinoceptor Subtypes in Rat OsteoclastsCellular Physiology and Biochemistry, 1999
- ATP is a potent stimulator of the activation and formation of rodent osteoclastsThe Journal of Physiology, 1998
- Non‐genomic inhibition of human P2X7 purinoceptor by 17β‐oestradiolThe Journal of Physiology, 1998
- ATP as an Osteoclast Regulator?The Journal of Physiology, 1997
- Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potenciesBritish Journal of Pharmacology, 1997
- Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblastsJournal of Bone and Mineral Research, 1995
- P2-Purinergic Receptors: Subtype-Associated Signaling Responses and StructureAnnual Review of Pharmacology and Toxicology, 1995
- Mechanisms of ATP-induced Ca2+ signaling in osteoclastsCellular Signalling, 1994
- Osteoblast‐like cells have a variable mixed population of purino/nucleotide receptorsFEBS Letters, 1993
- ATP Induces an Intracellular Calcium Pulse in OsteoclastsBiochemical and Biophysical Research Communications, 1993